ReproTox-KG: Toxicology Knowledge Graph for Structural Birth Defects
Evangelista, J. E.; Clarke, D. J.; Xie, Z.; Marino, G. B.; Utti, V.; Ahooyi, T. M.; Jenkins, S. L.; Taylor, D.; Bologa, C. G.; Yang, J. J.; Binder, J. L.; Kumar, P.; Lambert, C. G.; Grethe, J. S.; Wenger, E.; Oprea, T. I.; de Bono, B.; Ma'ayan, A.
Show abstract
Birth defects are functional and structural abnormalities that impact 1 in 33 births in the United States. Birth defects have been attributed to genetic as well as other factors, but for most birth defects there are no known causes. Small molecule drugs, cosmetics, foods, and environmental pollutants may cause birth defects when the mother is exposed to them during pregnancy. These molecules may interfere with the process of normal fetal development. To characterize associations between small molecule compounds and their potential to induce specific birth abnormalities, we gathered knowledge from multiple sources to construct a reproductive toxicity Knowledge Graph (ReproTox-KG) with an initial focus on associations between birth defects, drugs, and genes. Specifically, to construct ReproTox-KG we gathered data from drug/birth-defect associations from co-mentions in published abstracts, gene/birth-defect associations from genetic studies, drug- and preclinical-compound-induced gene expression data, known drug targets, genetic burden scores for all human genes, and placental crossing scores for all small molecules in ReproTox-KG. Using the data stored within ReproTox-KG, we scored 30,000 preclinical small molecules for their potential to induce birth defects. Querying the ReproTox-KG, we identified over 500 birth-defect/gene/drug cliques that can be used to explain molecular mechanisms for drug-induced birth defects. The ReproTox-KG is provided as curated tables and via a web-based user interface that can enable users to explore the associations between birth defects, approved and preclinical drugs, and human genes.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- predicTox: An integrated database of clinical risk frequencies and human gene expression signatures for cardiotoxic drugs 93%
- SynLethDB 2.0: A web-based knowledge graph database on synthetic lethality for novel anticancer drug discovery 93%
- DISEASES 2.0: a weekly updated database of disease-gene associations from text mining and data integration 93%
Similar papers in this journal
- Tissue-guided LASSO for prediction of clinical drug response using preclinical samples 94%
- Controlling astrocyte-mediated synaptic pruning signals for schizophrenia drug repurposing with Deep Graph Networks 94%
- Ranking of cell clusters in a single-cell RNA-sequencing analysis framework using prior knowledge 94%
Similar papers in this journal
- Combining explainable machine learning, demographic and multi-omic data to identify precision medicine strategies for inflammatory bowel disease 94%
- Exploring NCATS In-House Biomedical Data for Evidence-based Drug Repurposing 93%
- TargetDB: A target information aggregation tool and tractability predictor 93%
Similar papers in this journal
- Drug mechanism enrichment analysis improves prioritization of therapeutics for repurposing 94%
- Random Walk with Restart on multilayer networks: from node prioritisation to supervised link prediction and beyond 94%
- COMIC: Explainable Drug Repurposing via Contrastive Masking for Interpretable Connections 94%